CCO Independent Conference Coverage of the 2014 Genitourinary Cancers Symposium
Source: 2014 Genitourinary Cancers Symposium*

Conference Program


Slideset Module

Brian Rini, MD, FACP, and Nicholas J. Vogelzang, MD, provide expert perspective on the clinical applicability of key study findings in prostate cancer, renal cell carcinoma, bladder cancer, and germ cell tumors.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Incorporate key practice-changing clinical trial findings into the treatment of patients with genitourinary cancers to improve outcomes
  • Discuss with patients promising research directions in the treatment of genitourinary cancers
  • Offer participation in clinical trials to eligible patients with genitourinary cancers

Topics covered include:

  • 2014 Genitourinary Cancers Symposium


  • Brian Rini
    MD, FACP
    Nicholas J. Vogelzang

Credit Information

  • Release Date:
    April 08, 2014
  • Expiration Date:
    April 07, 2015
  • Physicians:
    maximum of 1.5 AMA PRA Category 1 Credits

Information on this Educational Activity

Disclosure of Relevant Financial Relationships

USF Health endorses the standards of the ACCME, ANCC, and ACPE that require everyone in a position to control the content of a CME/CE activity to disclose all financial relationships with commercial interests that are related to the content of the CME/CE activity. CME/CE activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when individuals in a position to control the content of CME/CE have a relevant financial relationship with a commercial interest which, therefore, may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.

USF Health will identify, review and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation. USF Health does not endorse any products or services.

Relevant financial relationships exist between the following individuals and commercial interests:


Brian Rini, MD, FACP

Staff Physician
Department of Solid Tumor Oncology and Urology
Cleveland Clinic Taussig Cancer Institute
Professor of Medicine
CCR/CWRU Lerner College of Medicine
Cleveland, Ohio

Brian Rini, MD, FACP, has disclosed that he has received consulting fees from Bristol-Myers Squibb, Merck, and Pfizer, and and funds for research support from Bristol-Myers Squibb, GlaxoSmithKline, Merck, Pfizer, and Roche.

Nicholas J. Vogelzang, MD

Research Medical Director 
Associate Chair
, GU Committee
US Oncology Research
Comprehensive Cancer Centers of Nevada
Professor of Medicine
University of Nevada School of Medicine
Las Vegas, Nevada

Nicholas J. Vogelzang, MD, has disclosed that he has received a salary from US Oncology; royalties from Up-to-Date; consulting fees from Amgen, Astellas, Caris, Endocyte, Janssen, Medivation, Novartis, and Pfizer; and fees for non-CME/CE services from AbbVie, Bayer, Celgene, Dendreon, GlaxoSmithKline, and Pfizer.


Terrence Fagan, 

Associate Managing Editor

Terrence Fagan has no significant financial relationships to disclose.

Gordon Kelley, 

Senior Clinical Editor

Gordon Kelley has no significant financial relationships to disclose.

Andrew D. Bowser, ELS, CCMEP

Editorial Director, Hematology/Oncology

Andrew D. Bowser, ELS, CCMEP, has no significant financial relationships to disclose.

Jim Mortimer, 

Senior Director, Oncology Programs and Partnership Development

Jim Mortimer has no significant financial relationships to disclose.

Planning Committee, USF Health OCPD staff members and the peer/content reviewer for this activity have no relevant financial relationships to disclose.

Disclosures are on file at the USF Health, Office of Continuing Professional Development.

The information provided at this CME/CE activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.

Unapproved Use Disclosure
USF Health requires CME faculty (speakers) to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty may discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

Privacy & Information
USF Health Office of Continuing Professional Development (OCPD) has created a privacy policy to demonstrate our commitment to guarding the privacy of our clients. The following statements disclose our practices on gathering and disseminating information for this web site.

The OCPD has security measures in place to protect the loss, misuse, and alteration of the information under our control. The OCPD does not share or sell any individual’s contact information, financial information, or unique identifiers to any commercial supporter, advertiser, or third party without the specific permission of the individual.

If you have any questions about this privacy policy, please contact USF Health OCPD, at

Equal Opportunity
USF is an Equal Opportunity/ Equal Access/ Affirmative Action Institution.


Target Audience

This program is intended for physicians and other healthcare professionals who provide care for patients with genitourinary cancer.


The goal of this activity is to improve participants’ competence at treating genitourinary cancer.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Incorporate key practice-changing clinical trial findings into the treatment of patients with genitourinary cancers to improve outcomes
  • Discuss with patients promising research directions in the treatment of genitourinary cancers
  • Offer participation in clinical trials to eligible patients with genitourinary cancers

Physician Continuing Medical Education

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint providership of USF Health and Clinical Care Options, LLC. USF Health is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

USF Health designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Commercial Support

This program is supported by educational grants from Takeda Oncology, and Teva Pharmaceuticals.


Program Medium

This program has been made available online.


Site Requirements

  • Internet Explorer 7+, Firefox 3+, Safari 3+, or Chrome
  • JavaScript enabled
  • 1024x768+ screen resolution
  • Adobe Flash Player

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from April 08, 2014, through April 07, 2015:

1. Register online at
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 70% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME activities completed can be found on the "CME Manager" page. There are no costs/fees for this activity.